ANTIHYPERLIPIDEMIC DRUGS MARKET ANALYSIS

Antihyperlipidemic Drugs Market, By Drug Class (Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, PCSK9 Inhibitors, Combination, and Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Jul 2023
Code : CMI5992
Pages :160
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Companies covered:

Sanofi S.A., Pfizer Inc., Mylan N.V, Amgen Inc., Abbvie Inc., Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd., Bristol-Myers Squibb Company, AstraZeneca plc, and Daiichi Sankyo Company, Limited, among others.

Global Antihyperlipidemic Drugs Market: Key Companies Insights

The global antihyperlipidemic drugs market is highly competitive. This is attributed to the increase in prevalence of hyperlipidemia across the world, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global antihyperlipidemic drugs market are Sanofi S.A., Pfizer Inc., Mylan N.V, Amgen Inc., Abbvie Inc., Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd., Bristol-Myers Squibb Company, AstraZeneca plc, and Daiichi Sankyo Company, Limited, among others.